FFCP PHASE1:Hg19::chr15:57592859..57592869,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=283663 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=296bp_to_ENST00000501726,NR_024433,uc010ugs.1,uc010ugt.1_5end | |||
|coexpression_cluster_id=C302 | |||
|description=CAGE_peak_5_at_LOC283663_5end | |||
|id=chr15:57592859..57592869,+ | |||
|ontology_enrichment_celltype=CL:0002032!1.37e-14!165;CL:0000837!1.37e-14!165;CL:0000037!7.81e-14!172;CL:0000566!7.81e-14!172;CL:0000988!7.43e-13!182;CL:0000763!3.78e-11!112;CL:0000049!3.78e-11!112;CL:0002619!3.93e-10!3;CL:0002087!2.78e-07!119;CL:0000945!5.63e-07!24;CL:0000826!5.63e-07!24;CL:0000738!6.56e-07!140 | |||
|ontology_enrichment_celltype_v019= | |||
|ontology_enrichment_celltype_v019_2=CL:0000763,6.23e-13,108;CL:0000049,6.23e-13,108;CL:0002032,9.40e-09,161;CL:0000837,9.40e-09,161;CL:0000037,2.15e-08,168;CL:0000988,5.65e-08,177 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:2531!8.64e-18!51;DOID:0060083!8.64e-18!51;DOID:8692!1.99e-17!31;DOID:1240!1.14e-16!39;DOID:12603!3.83e-08!1;DOID:225!5.07e-08!1 | |||
|ontology_enrichment_disease_v019=DOID:8692;5.10e-32;31!DOID:1240;3.97e-20;39!DOID:2531;1.58e-12;51!DOID:0060083;1.58e-12;51 | |||
|ontology_enrichment_disease_v019_2=DOID:8692,5.51e-33,31;DOID:1240,2.59e-26,39;DOID:2531,3.25e-20,51;DOID:0060083,3.25e-20,51;DOID:0050686,1.31e-07,137 | |||
|ontology_enrichment_uberon=UBERON:0002106!8.94e-10!3;UBERON:0004854!8.94e-10!3;UBERON:0009034!8.94e-10!3;UBERON:0002095!8.94e-10!3;UBERON:0004782!8.94e-10!3;UBERON:0003281!8.94e-10!3;UBERON:0009664!8.94e-10!3;UBERON:0002296!8.94e-10!3;UBERON:0005602!8.94e-10!3;UBERON:0001179!8.94e-10!3;UBERON:0006293!8.94e-10!3;UBERON:0004177!4.85e-09!7;UBERON:0001154!2.69e-08!1;UBERON:0001153!2.69e-08!1;UBERON:0002372!6.24e-08!1;UBERON:0001961!6.24e-08!1;UBERON:0001744!6.24e-08!1;UBERON:0001735!6.24e-08!1;UBERON:0002193!8.71e-08!112;UBERON:0002390!2.14e-07!102;UBERON:0003061!2.14e-07!102 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0764134057479513,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.223915474239924,0,0.257575567634187,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.580418477257168,1.70215567407342,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.546138611262131,0,0,0,0,0,0,0,0.587237189370939,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.148631162288728,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238231775457789,0,0,0.540031437238115,0,0,0,0,0.185803175125719,0,0,0,0,0,0,0,0,0,1.25343916618419,0,0,0.802940375518498,2.01799707191048,1.70338495076131,1.71752672377882,0.921722292925374,0.671028323677248,0,5.47086667125713,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.276283915531148,0,0,0.123084805461069,0,0,0,2.04628948090749,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.243585196761792,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163565394255844,0,0,0,0,0.106691729694141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0644578879735772,0.0999411559249289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0620747142958579,0,0,0,0,0,0.0673520530145875,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p5@LOC283663 | |||
}} |
Revision as of 23:45, 11 January 2014
Short description: | p5@LOC283663 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_5_at_LOC283663_5end |
Coexpression cluster: | C302_acute_peripheral_Neutrophils_NK_myelodysplastic_CD34_carcinoid |
Association with transcript: | 296bp_to_ENST00000501726, NR_024433, uc010ugs.1, uc010ugt.1_5end |
EntrezGene: | LOC283663 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
myeloid cell | 6.23e-13 | 108 |
common myeloid progenitor | 6.23e-13 | 108 |
hematopoietic oligopotent progenitor cell | 9.40e-09 | 161 |
hematopoietic multipotent progenitor cell | 9.40e-09 | 161 |
hematopoietic stem cell | 2.15e-08 | 168 |
hematopoietic cell | 5.65e-08 | 177 |
Ontology term | p-value | n |
---|---|---|
myeloid leukemia | 5.51e-33 | 31 |
leukemia | 2.59e-26 | 39 |
hematologic cancer | 3.25e-20 | 51 |
immune system cancer | 3.25e-20 | 51 |
organ system cancer | 1.31e-07 | 137 |